Assessment of Infusional 5-Fluorouracil Schedule and Dose Intensity: A Southwest Oncology Group and Eastern Cooperative Oncology Group Study

Meta-Analysis Group in Cancer, 1992, Modulation of fluorouracil by leucovorin in patients with advanced colorectal cancer: evidence in terms of response rate. Advanced Colorectal Cancer Meta-Analysis Project, J Clin Oncol, 10, 896, 10.1200/JCO.1992.10.6.896 Meta-Analysis Group in Cancer, 1998, Efficacy of intravenous continuous infusion of fluorouracil compared with bolus administration in advanced colorectal cancer, J Clin Oncol, 16, 301, 10.1200/JCO.1998.16.1.301 Laufman, 1993, A randomized double-blind trial of fluorouracil plus placebo versus fluorouracil plus oral leucovorin in patients with metastatic colorectal cancer, J Clin Oncol, 11, 1888, 10.1200/JCO.1993.11.10.1888 Moertel, 1990, Levamisole and fluorouracil for adjuvant treatment of resected colon cancer, N Engl J Med, 322, 352, 10.1056/NEJM199002083220602 Wolmark, 1993, The benefit of leucovorin modulated 5-fluorouracil as post-operative treatment for primary colon cancer: results from the National Surgical Adjuvant Breast and Bowel Project Protocol C03, J Clin Oncol, 11, 1879, 10.1200/JCO.1993.11.10.1879 1990, NIH Consensus Conference. Adjuvant therapy for patients with colon and rectal cancer, JAMA, 264, 1444, 10.1001/jama.1990.03450110090034 Lokich, 1981, Phase I study of protracted venous infusion of 5-fluorouracil, Cancer, 48, 2565, 10.1002/1097-0142(19811215)48:12<2565::AID-CNCR2820481204>3.0.CO;2-E Shah, 1985, 5-FU infusion in advanced colorectal cancer: a comparison of three dose schedules, Cancer Treat Rep, 69, 739 Elsaleh, 2000, Association of tumor site and sex with survival benefit from adjuvant chemotherapy in colorectal cancer, Lancet, 355, 1745, 10.1016/S0140-6736(00)02261-3 Dignam, 2003, Prognosis after rectal cancer in blacks and whites participating in adjuvant therapy randomized trials, J Clin Oncol, 21, 413, 10.1200/JCO.2003.02.004 Saltz, 2000, Irinotecan plus fluorouracil and leucovorin for metastatic colorectal cancer, N Engl J Med, 343, 905, 10.1056/NEJM200009283431302 Douillard, 2000, Irinotecan combined with fluorouracil compared with fluorouracil alone as first-line treatment for metastatic colorectal cancer: a multicentre randomised trial, Lancet, 355, 1041, 10.1016/S0140-6736(00)02034-1 Rothenberg, 2001, Mortality associated with irinotecan plus fluorouracil/leucovorin: summary findings of an independent panel, J Clin Oncol, 19, 3801, 10.1200/JCO.2001.19.18.3801 DeGramont, 2000, Leucovorin and 5-fluorouracil with or without oxaliplatin in advanced colorectal cancer, J Clin Oncol, 18, 2938, 10.1200/JCO.2000.18.16.2938 Giachetti, 2000, Phase III multicenter randomized trial of oxaliplatin added to chronomodulated fluorouracil-leucovorin as first-line treatment of metastatic colorectal cancer, J Clin Oncol, 18, 136, 10.1200/JCO.2000.18.1.136 Goldberg, 2004, A randomized controlled trial of fluorouracil plus leucovorin, irinotecan and oxaliplatin combinations in patients with previously untreated metastatic colorectal cancer, J Clin Oncol, 22, 23, 10.1200/JCO.2004.09.046 Rothenberg, 2003, Superiority of oxaliplatin and fluorouracil-leucovorin compared with either therapy alone in patients with progressive colorectal cancer after irinotecan and fluorouracil-leucovorin: interim results of a phase III trial, J Clin Oncol, 21, 2049, 10.1200/JCO.2003.11.126 Delaunoit, 2004, Mortality associated with daily bolus 5-fluorouracil/leucovorin administered in combination with either irinotecan or oxaliplatin: results from Intergroup Trial N9741, Cancer, 101, 2170, 10.1002/cncr.20594 Van Cutsem, 2001, Oral capecitabine compared with intravenous fluorouracil plus leucovorin in patients with metastatic colorectal cancer: results of a large phase III study, J Clin Oncol, 19, 4097, 10.1200/JCO.2001.19.21.4097 Bajetta, 2004, Randomized multicenter phase II trial of two different schedules of irinotecan combined with capecitabine as first-line treatment in metastatic colorectal carcinoma, Cancer, 100, 279, 10.1002/cncr.11910 Diaz-Rubio, 2002, Capecitabine (Xeloda) in combination with oxaliplatin: a phase I, dose-escalation study in patients with advanced or metastatic solid tumors, Ann Oncol, 13, 558, 10.1093/annonc/mdf065 Dunst, 2002, Phase I trial evaluating the concurrent combination of radiotherapy and capecitabine in rectal cancer, J Clin Oncol, 20, 3983, 10.1200/JCO.2002.02.049 Leichman, 1995, Phase II study of fluorouracil and its modulation in advanced colorectal cancer: a Southwest Oncology Group study, J Clin Oncol, 13, 1303, 10.1200/JCO.1995.13.6.1303 O'Dwyer, 2001, J Clin Oncol, 19, 2413, 10.1200/JCO.2001.19.9.2413 Poon, 1989, Biochemical modulation of fluorouracil: evidence of significant improvement of survival and quality of life in patients with advanced colorectal cancer, J Clin Oncol, 7, 1407, 10.1200/JCO.1989.7.10.1407